DMG — Dr Miele Cosmed SA Cashflow Statement
0.000.00%
Last trade - 00:00
- PLN471.63m
- PLN523.80m
- PLN444.48m
- 93
- 40
- 71
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 4.93 | 31.3 | 13.3 | -2.1 | 27.2 |
Depreciation | |||||
Non-Cash Items | 1.18 | 1.53 | 1.54 | 2.97 | 4.68 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.21 | -17.5 | 0.665 | -6.41 | -12.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 14.7 | 26.3 | 26.1 | 5.8 | 31.3 |
Capital Expenditures | -3.57 | -8.84 | -17.7 | -6.55 | -9.69 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2.25 | 3.1 | 0.337 | 7.16 | -3.21 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Cash from Investing Activities | -1.32 | -5.74 | -17.4 | 0.602 | -12.9 |
Financing Cash Flow Items | -2.56 | -1.75 | -1.42 | -3.41 | -4.39 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -12.4 | -7.41 | -15.5 | -8.35 | -13.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.982 | 13.1 | -6.81 | -1.95 | 4.91 |